Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
MSCs from umbilical cord blood and Wharton’s jelly cells (WJCs) have several properties in common, such as poor ability to differentiate into adipocytes (PMID: 17053211, 16410387, 15277708), shorter doubling times than bone marrow stem cells, and greater number of passages to senescence (PMID: 17053211, 16410387, 17332507, 17053209, 15277708).
MSCs from bone marrow, umbilical cord blood, and Wharton’s jelly differ in the formation of CFU-F. For bone marrow the frequency is estimated to be in the range of 1–10 CFU-F per 1×106 mononuclear cells (MNCs), whereas values reported for umbilical cord blood range from one CFU-F clone per 1×108 MNCs to 1–3 CFU-F per 1×106 MNCs (PMID: 15257936, 11760145). In contrast, cells derived from Wharton’s jelly exhibit a higher frequency of CFU-F formation (PMID: 17053211 ,15671145).
At a glance: Kits and reagents for the preparation of umbilical cord samples
Use | Comments | Product |
---|---|---|
Tissue dissociation | Gentle and effective generation of single-cell suspension | Umbilical Cord Dissociation Kit, human |
Human umbilical cord tissue can be dissociated into a single-cell suspension by combining mechanical dissociation with enzymatic degradation of the extracellular adhesion proteins that maintain the tissue structural integrity.
Using the Umbilical Cord Dissociation Kit, human is an efficient but gentle way to generate a single-cell suspension from human umbilical cord tissue. The kit was originally developed for the quality control of frozen umbilical cord samples in tissue banks based on the detection of MSCs by flow cytometry immediately after dissociation, without lengthy cultivation of cells. The umbilical cord is first soaked with enzymes that degrade the extracellular matrix. Single cells are freed from the extracellular matrix using the gentleMACS™ Dissociator, and any remaining particles are removed by filtration using MACS® SmartStrainers. Cells are processed immediately for downstream applications, such as cell culture, cell separation, or cell analysis.Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.